Global Amblyopia Treatment Market
Global Amblyopia Treatment Market

Amblyopia Treatment Comprehensive Study by Modern Treatment (Dig Rush, Falling Blocks, I-BiT, Occlu-Pad or Occlu-Tab, Vivid Vision, Others), Classical (Optical Correction, Patching, Pharmacological Treatment, Perceptual Learning), Amblyopia (Deprivation Amblyopia, Anisometropic Amblyopia, Strabismic Amblyopia, Reverse Amblyopia, Others) Players and Region - Global Market Outlook to 2026

Amblyopia Treatment Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Sep 2021 Edition 239 Pages 218 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
Amblyopia is majorly affected in early childhood. Its symptoms include a wandering eye, eyes that may not appear to work together, or poor depth perception. Today it is affecting up to 3.7% of the global population. Amblyopia is also known as the lazy eye. With the increase in investment in research and development clinicians are interested in new binocular treatments because of the rapid development in new technologies. There are various therapies are emerging in this amblyopia treatment industry. According to the industry experts, the North American region is expected to capture a major market share because of the increase in the number of cases and rising awareness towards treatment areas.This growth is primarily driven by Nearly 3% of Amblyopia Treatment Remain Untreated and Growing Demand in the Asia Pacific Regions Because of Increase in Population.

Globally, a noticeable market trend is evident Atropine Sulfate Eye Drops are Widely Used for the Treatment of Amblyopia. Major Players, such as 3M (United States), Vivid Vision, Inc. (United States), NovaSight (Israel), RevitalVision (Israel), Hilco Vision (United States), Krafty Eye Patches (United States), Fresnel Prism and Lens Co. (United States), OpthoPatch (United States), Lancastle International Ltd. (United Kingdom) and HOYA Vision Care Company (Thailand) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In Mar 2021, The Israeli start-up specializing in ground-breaking vision care solutions based on AI and eye-tracking technology revealed that they got approval for its CureSight™ lazy eye digital treatment device.

Market Drivers
  • Nearly 3% of Amblyopia Treatment Remain Untreated
  • Growing Demand in the Asia Pacific Regions Because of Increase in Population

Market Trend
  • Atropine Sulfate Eye Drops are Widely Used for the Treatment of Amblyopia

Restraints
  • Lack of Awareness

Opportunities
Emerging Therapies for Amblyopia and Perceptual Learning Represent an Opportunity to Treat Adults with Amblyopia
Challenges
The Rise in Concern towards Amblyopia Treatment

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Amblyopia Treatment Study Sheds Light on
— The Amblyopia Treatment Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Amblyopia Treatment industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Amblyopia Treatment industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Frequently Asked Questions (FAQ):

1. What are the years considered in the Amblyopia Treatment Market?
Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026

2. Who are the key players profiled in the Amblyopia Treatment Market?
Companies that are profiled in Global Amblyopia Treatment Market are 3M (United States), Vivid Vision, Inc. (United States), NovaSight (Israel), RevitalVision (Israel), Hilco Vision (United States), Krafty Eye Patches (United States), Fresnel Prism and Lens Co. (United States), OpthoPatch (United States), Lancastle International Ltd. (United Kingdom) and HOYA Vision Care Company (Thailand) etc.

3. What is Amblyopia Treatment Market?
Amblyopia is majorly affected in early childhood. Its symptoms include a wandering eye, eyes that may not appear to work together, or poor depth perception. Today it is affecting up to 3.7% of the global population. Amblyopia is also known as the lazy eye. With the increase in investment in research and development clinicians are interested in new binocular treatments because of the rapid development in new technologies. There are various therapies are emerging in this amblyopia treatment industry. According to the industry experts, the North American region is expected to capture a major market share because of the increase in the number of cases and rising awareness towards treatment areas.
Report Objectives / Segmentation Covered
By Modern Treatment
  • Dig Rush
  • Falling Blocks
  • I-BiT
  • Occlu-Pad or Occlu-Tab
  • Vivid Vision
  • Others

By Classical
  • Optical Correction
  • Patching
  • Pharmacological Treatment
  • Perceptual Learning

By Amblyopia
  • Deprivation Amblyopia
  • Anisometropic Amblyopia
  • Strabismic Amblyopia
  • Reverse Amblyopia
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Nearly 3% of Amblyopia Treatment Remain Untreated
      • 3.2.2. Growing Demand in the Asia Pacific Regions Because of Increase in Population
    • 3.3. Market Challenges
      • 3.3.1. The Rise in Concern towards Amblyopia Treatment
    • 3.4. Market Trends
      • 3.4.1. Atropine Sulfate Eye Drops are Widely Used for the Treatment of Amblyopia
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Amblyopia Treatment, by Modern Treatment, Classical, Amblyopia and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Amblyopia Treatment (Value)
      • 5.2.1. Global Amblyopia Treatment by: Modern Treatment (Value)
        • 5.2.1.1. Dig Rush
        • 5.2.1.2. Falling Blocks
        • 5.2.1.3. I-BiT
        • 5.2.1.4. Occlu-Pad or Occlu-Tab
        • 5.2.1.5. Vivid Vision
        • 5.2.1.6. Others
      • 5.2.2. Global Amblyopia Treatment by: Classical (Value)
        • 5.2.2.1. Optical Correction
        • 5.2.2.2. Patching
        • 5.2.2.3. Pharmacological Treatment
        • 5.2.2.4. Perceptual Learning
      • 5.2.3. Global Amblyopia Treatment Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Amblyopia Treatment (Price)
  • 6. Amblyopia Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Vivid Vision, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. NovaSight (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. RevitalVision (Israel)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Hilco Vision (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Krafty Eye Patches (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Fresnel Prism and Lens Co. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. OpthoPatch (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lancastle International Ltd. (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. HOYA Vision Care Company (Thailand)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Amblyopia Treatment Sale, by Modern Treatment, Classical, Amblyopia and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Amblyopia Treatment (Value)
      • 7.2.1. Global Amblyopia Treatment by: Modern Treatment (Value)
        • 7.2.1.1. Dig Rush
        • 7.2.1.2. Falling Blocks
        • 7.2.1.3. I-BiT
        • 7.2.1.4. Occlu-Pad or Occlu-Tab
        • 7.2.1.5. Vivid Vision
        • 7.2.1.6. Others
      • 7.2.2. Global Amblyopia Treatment by: Classical (Value)
        • 7.2.2.1. Optical Correction
        • 7.2.2.2. Patching
        • 7.2.2.3. Pharmacological Treatment
        • 7.2.2.4. Perceptual Learning
      • 7.2.3. Global Amblyopia Treatment Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Amblyopia Treatment (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Amblyopia Treatment: by Modern Treatment(USD Million)
  • Table 2. Amblyopia Treatment Dig Rush , by Region USD Million (2015-2020)
  • Table 3. Amblyopia Treatment Falling Blocks , by Region USD Million (2015-2020)
  • Table 4. Amblyopia Treatment I-BiT , by Region USD Million (2015-2020)
  • Table 5. Amblyopia Treatment Occlu-Pad or Occlu-Tab , by Region USD Million (2015-2020)
  • Table 6. Amblyopia Treatment Vivid Vision , by Region USD Million (2015-2020)
  • Table 7. Amblyopia Treatment Others , by Region USD Million (2015-2020)
  • Table 8. Amblyopia Treatment: by Classical(USD Million)
  • Table 9. Amblyopia Treatment Optical Correction , by Region USD Million (2015-2020)
  • Table 10. Amblyopia Treatment Patching , by Region USD Million (2015-2020)
  • Table 11. Amblyopia Treatment Pharmacological Treatment , by Region USD Million (2015-2020)
  • Table 12. Amblyopia Treatment Perceptual Learning , by Region USD Million (2015-2020)
  • Table 13. South America Amblyopia Treatment, by Country USD Million (2015-2020)
  • Table 14. South America Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 15. South America Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 16. South America Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 17. Brazil Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 18. Brazil Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 19. Brazil Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 20. Argentina Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 21. Argentina Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 22. Argentina Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 23. Rest of South America Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 24. Rest of South America Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 25. Rest of South America Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 26. Asia Pacific Amblyopia Treatment, by Country USD Million (2015-2020)
  • Table 27. Asia Pacific Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 28. Asia Pacific Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 29. Asia Pacific Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 30. China Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 31. China Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 32. China Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 33. Japan Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 34. Japan Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 35. Japan Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 36. India Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 37. India Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 38. India Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 39. South Korea Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 40. South Korea Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 41. South Korea Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 42. Taiwan Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 43. Taiwan Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 44. Taiwan Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 45. Australia Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 46. Australia Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 47. Australia Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 51. Europe Amblyopia Treatment, by Country USD Million (2015-2020)
  • Table 52. Europe Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 53. Europe Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 54. Europe Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 55. Germany Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 56. Germany Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 57. Germany Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 58. France Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 59. France Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 60. France Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 61. Italy Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 62. Italy Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 63. Italy Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 64. United Kingdom Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 65. United Kingdom Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 66. United Kingdom Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 67. Netherlands Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 68. Netherlands Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 69. Netherlands Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 70. Rest of Europe Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 71. Rest of Europe Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 72. Rest of Europe Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 73. MEA Amblyopia Treatment, by Country USD Million (2015-2020)
  • Table 74. MEA Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 75. MEA Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 76. MEA Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 77. Middle East Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 78. Middle East Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 79. Middle East Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 80. Africa Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 81. Africa Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 82. Africa Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 83. North America Amblyopia Treatment, by Country USD Million (2015-2020)
  • Table 84. North America Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 85. North America Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 86. North America Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 87. United States Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 88. United States Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 89. United States Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 90. Canada Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 91. Canada Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 92. Canada Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 93. Mexico Amblyopia Treatment, by Modern Treatment USD Million (2015-2020)
  • Table 94. Mexico Amblyopia Treatment, by Classical USD Million (2015-2020)
  • Table 95. Mexico Amblyopia Treatment, by Amblyopia USD Million (2015-2020)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Amblyopia Treatment: by Modern Treatment(USD Million)
  • Table 107. Amblyopia Treatment Dig Rush , by Region USD Million (2021-2026)
  • Table 108. Amblyopia Treatment Falling Blocks , by Region USD Million (2021-2026)
  • Table 109. Amblyopia Treatment I-BiT , by Region USD Million (2021-2026)
  • Table 110. Amblyopia Treatment Occlu-Pad or Occlu-Tab , by Region USD Million (2021-2026)
  • Table 111. Amblyopia Treatment Vivid Vision , by Region USD Million (2021-2026)
  • Table 112. Amblyopia Treatment Others , by Region USD Million (2021-2026)
  • Table 113. Amblyopia Treatment: by Classical(USD Million)
  • Table 114. Amblyopia Treatment Optical Correction , by Region USD Million (2021-2026)
  • Table 115. Amblyopia Treatment Patching , by Region USD Million (2021-2026)
  • Table 116. Amblyopia Treatment Pharmacological Treatment , by Region USD Million (2021-2026)
  • Table 117. Amblyopia Treatment Perceptual Learning , by Region USD Million (2021-2026)
  • Table 118. South America Amblyopia Treatment, by Country USD Million (2021-2026)
  • Table 119. South America Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 120. South America Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 121. South America Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 122. Brazil Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 123. Brazil Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 124. Brazil Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 125. Argentina Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 126. Argentina Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 127. Argentina Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 128. Rest of South America Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 129. Rest of South America Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 130. Rest of South America Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 131. Asia Pacific Amblyopia Treatment, by Country USD Million (2021-2026)
  • Table 132. Asia Pacific Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 133. Asia Pacific Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 134. Asia Pacific Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 135. China Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 136. China Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 137. China Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 138. Japan Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 139. Japan Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 140. Japan Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 141. India Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 142. India Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 143. India Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 144. South Korea Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 145. South Korea Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 146. South Korea Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 147. Taiwan Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 148. Taiwan Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 149. Taiwan Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 150. Australia Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 151. Australia Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 152. Australia Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 153. Rest of Asia-Pacific Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 154. Rest of Asia-Pacific Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 155. Rest of Asia-Pacific Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 156. Europe Amblyopia Treatment, by Country USD Million (2021-2026)
  • Table 157. Europe Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 158. Europe Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 159. Europe Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 160. Germany Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 161. Germany Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 162. Germany Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 163. France Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 164. France Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 165. France Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 166. Italy Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 167. Italy Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 168. Italy Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 169. United Kingdom Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 170. United Kingdom Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 171. United Kingdom Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 172. Netherlands Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 173. Netherlands Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 174. Netherlands Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 175. Rest of Europe Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 176. Rest of Europe Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 177. Rest of Europe Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 178. MEA Amblyopia Treatment, by Country USD Million (2021-2026)
  • Table 179. MEA Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 180. MEA Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 181. MEA Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 182. Middle East Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 183. Middle East Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 184. Middle East Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 185. Africa Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 186. Africa Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 187. Africa Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 188. North America Amblyopia Treatment, by Country USD Million (2021-2026)
  • Table 189. North America Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 190. North America Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 191. North America Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 192. United States Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 193. United States Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 194. United States Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 195. Canada Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 196. Canada Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 197. Canada Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 198. Mexico Amblyopia Treatment, by Modern Treatment USD Million (2021-2026)
  • Table 199. Mexico Amblyopia Treatment, by Classical USD Million (2021-2026)
  • Table 200. Mexico Amblyopia Treatment, by Amblyopia USD Million (2021-2026)
  • Table 201. Research Programs/Design for This Report
  • Table 202. Key Data Information from Secondary Sources
  • Table 203. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Amblyopia Treatment: by Modern Treatment USD Million (2015-2020)
  • Figure 5. Global Amblyopia Treatment: by Classical USD Million (2015-2020)
  • Figure 6. South America Amblyopia Treatment Share (%), by Country
  • Figure 7. Asia Pacific Amblyopia Treatment Share (%), by Country
  • Figure 8. Europe Amblyopia Treatment Share (%), by Country
  • Figure 9. MEA Amblyopia Treatment Share (%), by Country
  • Figure 10. North America Amblyopia Treatment Share (%), by Country
  • Figure 11. Global Amblyopia Treatment share by Players 2020 (%)
  • Figure 12. Global Amblyopia Treatment share by Players (Top 3) 2020(%)
  • Figure 13. Global Amblyopia Treatment share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 16. 3M (United States) Revenue: by Geography 2020
  • Figure 17. Vivid Vision, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Vivid Vision, Inc. (United States) Revenue: by Geography 2020
  • Figure 19. NovaSight (Israel) Revenue, Net Income and Gross profit
  • Figure 20. NovaSight (Israel) Revenue: by Geography 2020
  • Figure 21. RevitalVision (Israel) Revenue, Net Income and Gross profit
  • Figure 22. RevitalVision (Israel) Revenue: by Geography 2020
  • Figure 23. Hilco Vision (United States) Revenue, Net Income and Gross profit
  • Figure 24. Hilco Vision (United States) Revenue: by Geography 2020
  • Figure 25. Krafty Eye Patches (United States) Revenue, Net Income and Gross profit
  • Figure 26. Krafty Eye Patches (United States) Revenue: by Geography 2020
  • Figure 27. Fresnel Prism and Lens Co. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Fresnel Prism and Lens Co. (United States) Revenue: by Geography 2020
  • Figure 29. OpthoPatch (United States) Revenue, Net Income and Gross profit
  • Figure 30. OpthoPatch (United States) Revenue: by Geography 2020
  • Figure 31. Lancastle International Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Lancastle International Ltd. (United Kingdom) Revenue: by Geography 2020
  • Figure 33. HOYA Vision Care Company (Thailand) Revenue, Net Income and Gross profit
  • Figure 34. HOYA Vision Care Company (Thailand) Revenue: by Geography 2020
  • Figure 35. Global Amblyopia Treatment: by Modern Treatment USD Million (2021-2026)
  • Figure 36. Global Amblyopia Treatment: by Classical USD Million (2021-2026)
  • Figure 37. South America Amblyopia Treatment Share (%), by Country
  • Figure 38. Asia Pacific Amblyopia Treatment Share (%), by Country
  • Figure 39. Europe Amblyopia Treatment Share (%), by Country
  • Figure 40. MEA Amblyopia Treatment Share (%), by Country
  • Figure 41. North America Amblyopia Treatment Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • 3M (United States)
  • Vivid Vision, Inc. (United States)
  • NovaSight (Israel)
  • RevitalVision (Israel)
  • Hilco Vision (United States)
  • Krafty Eye Patches (United States)
  • Fresnel Prism and Lens Co. (United States)
  • OpthoPatch (United States)
  • Lancastle International Ltd. (United Kingdom)
  • HOYA Vision Care Company (Thailand)
Additional players considered in the study are as follows:
Good-Lite (United States) , OrtopadUSA (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation